ChemInform Abstract: POTENTIELLE ANTINEOPLASTICA 4. MITT. 2‐AMINO‐4‐METHYL‐6‐PHENYL‐5‐ARYLAZOPYRIMIDINE

Publisher： John Wiley & Sons Inc

E-ISSN： 2199-2932|1|41|chin.197041358-chin.197041358

ISSN： 0300-5151

Source： Chemischer Informationsdienst. Organische Chemie, Vol.1, Iss.41, 1970-10, pp. : no-no

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ChemInform Abstract: POTENTIELLE ANTINEOPLASTICA 2. MITT. 1‐THIOCARBAMOYL‐3‐METHYL‐4‐ARYLHYDRAZONO‐2‐PYRAZOLIN‐5‐ONE, 2‐AMINO‐4‐PHENYL‐5‐ARYLAZOTHIAZOLE UND N‐PHENYL‐N′‐2‐(4‐PHENYL‐5‐ARYLAZOTHIAZOLYL)‐THIOCARBAMIDE

By  

Chemischer Informationsdienst. Organische Chemie, Vol. 1, Iss. 26, 1970-06 ,pp. : no-no

John Wiley & Sons Inc

Access to resources Recommend Favorite

ChemInform Abstract: POTENTIELLE ANTINEOPLASTICA 3. MITT. 1‐THIOCARBAMOYL‐3‐METHYL‐4‐ARYLAZO‐5‐METHYL(ODER PHENYL)‐PYRAZOLE

By  

Chemischer Informationsdienst. Organische Chemie, Vol. 1, Iss. 34, 1970-08 ,pp. : no-no

John Wiley & Sons Inc

Access to resources Recommend Favorite

ChemInform Abstract: NEUE VERBINDUNGEN, POTENTIELLE ANTINEOPLASTICA 6. MITT. 2,4‐DIAMINO‐6‐HYDROXY‐5‐ARYLAZOPYRIMIDINE UND 1,3‐DIMETHYL‐5‐ARYLHYDRAZONOALLOXANE

By  

Chemischer Informationsdienst. Organische Chemie, Vol. 2, Iss. 10, 1971-03 ,pp. : no-no

John Wiley & Sons Inc

Access to resources Recommend Favorite

ChemInform Abstract: POTENTIELLE ANTIDIABETICA 6. MITT. 3‐METHYL‐4‐ARYLHYDRAZONO‐2‐ISOXAZOLIN‐5‐ONE (I) UND 3‐METHYL‐4‐ARYLAZO‐5‐(METHYL/PHENYL)‐ISOXAZOLE (II/III)

By  

Chemischer Informationsdienst. Organische Chemie, Vol. 2, Iss. 11, 1971-03 ,pp. : no-no

John Wiley & Sons Inc

Access to resources Recommend Favorite

ChemInform Abstract: POTENTIELLE ANTIDIABETIKA 10. MITT. 4‐ARYLAZO‐N(1)‐BENZOYL‐3,5‐METHYL(PHENYL)‐PYRAZOLE UND 4‐ARYLHYDRAZONO‐N(1)‐BENZOYL‐3‐METHYL‐2‐PYRAZOLINONE‐(5)

By  

Chemischer Informationsdienst. Organische Chemie, Vol. 2, Iss. 48, 1971-11 ,pp. : no-no

John Wiley & Sons Inc

Access to resources Recommend Favorite